2,291 results on '"James, Stefan"'
Search Results
152. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: A substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial
153. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: An APEX AMI substudy
154. Bioresorbable Stents in PCI
155. Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)
156. Novel Trial Designs: Lessons Learned from Thrombus Aspiration During ST-Segment Elevation Myocardial Infarction in Scandinavia (TASTE) Trial
157. Percutaneous Closure in Transfemoral Aortic Valve Implantation: A Single-Centre Experience
158. Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis
159. Surgical Removal of a Detached Mitral Valve Repair Clip to Resolve Cardiogenic Shock
160. Benchmarking Observational Analyses Before Using Them to Address Questions Trials Do Not Answer: An Application to Coronary Thrombus Aspiration
161. Cost–effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial
162. Minimum Core Data Elements for Evaluation of TAVR
163. Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients: The GENERATIONS Trial, A Pharmacodynamic and Pharmacokinetic Study in Stable Coronary Artery Disease Patients
164. Quantitative ST-depression in Acute Coronary Syndromes: the PLATO Electrocardiographic Substudy
165. Long-Term Results After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions: Nordic Bifurcation Study 5-Year Follow-Up Results
166. Angiographic Outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes)
167. Additional file 1 of A physically active lifestyle is associated with lower long-term incidence of bipolar disorder in a population-based, large-scale study
168. Learning-by-doing and productivity growth among high-skilled workers: Evidence from the treatment of heart attacks
169. Randomized trials fit for the 21st century. A joint opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation
170. Minimum Core Data Elements for Evaluation of TAVR A Scientific Statement by PASSION CV, HVC, and TVT Registry
171. Oxygen Therapy in Suspected Acute Myocardial Infarction
172. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
173. New Method for Assessing the Effect of Driving Distance to Hospital Care: Using OpenStreetMap Routing in Cardiovascular Research
174. Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes
175. Corrigendum to “A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease” [Am Heart J 181 (2016) 92–100]
176. Thrombus Aspiration in ST-Segment–Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration
177. Clinical Impact of Second-Generation Everolimus-Eluting Stent Compared With First-Generation Drug-Eluting Stents in Diabetes Mellitus Patients: Insights From a Nationwide Coronary Intervention Register
178. Enoxaparin for anticoagulation in patients undergoing PCI: An effective and safe alternative to unfractionated heparin
179. A Global Risk Approach to Identify Patients With Left Main or 3-Vessel Disease Who Could Safely and Efficaciously Be Treated With Percutaneous Coronary Intervention: The SYNTAX Trial at 3 Years
180. Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial
181. Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent Surgery
182. Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes
183. Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study
184. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial
185. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
186. The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial: Results of the Continuous Electrocardiographic Assessment Substudy
187. Transcatheter Implantation of the MONARC Coronary Sinus Device for Mitral Regurgitation: 1-Year Results From the EVOLUTION Phase I Study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for The Treatment of Mitral Regurgitation)
188. Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention—A case-control study
189. Pulmonary Function in Patients With Acute Coronary Syndrome Treated With Ticagrelor or Clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] Pulmonary Function Substudy)
190. Bivalirudin Versus Heparin Monotherapy in ST-Segment–Elevation Myocardial Infarction
191. Clinical Outcomes After Surgical Revascularization Using No-Touch Versus Conventional Saphenous Vein Grafts: Mid-Term Follow-Up of Propensity Score Matched Cohorts
192. Myocardial infarction after elective percutaneous coronary intervention—which cardiac troponin cut-off to use?
193. Abstract 13221: The Biomarker-Based ABC-ACS (Age, Biomarkers, Clinical History) Score Can Predict Major Bleeding Better Than Other Contemporary Scores in Patients on Dual Antiplatelet Therapy After Coronary Revascularization: Results of a Large Derivation and Validation Study
194. Abstract 10426: Worse Clinical Outcomes in Patients with Acute Coronary Syndrome and Prior or New Onset Heart Failure: Insights from 47,474 Patients in a Pooled Analysis of Randomized Clinical Trials
195. TCT-84 Serial NIRS-IVUS Assessment of Changes in Coronary Lumen Area During 2-Year Follow-Up: Insights From the PROSPECT ABSORB Trial
196. TCT-79 Changes in Coronary Lipid Composition During 2-Year Follow-Up After Acute Myocardial Infarction: Serial NIRS-IVUS Assessment From the PROSPECT ABSORB Trial
197. Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients
198. Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction—a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial)
199. Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study
200. Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.